(Q39538570)

English

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.

scientific article published on August 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Christine E Hallgreen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ebba Holme Hansen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

L Aagaard

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

0 references

publication date

1 August 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

International Journal of Obesity

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

40

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1742-1747

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

https://scigraph.springernature.com/pub.10.1038/ijo.2016.135

0 references

Anti-Obesity Drugs: A Review about Their Effects and Safety

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Safety of antiobesity drugs

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Use of prescription antiobesity drugs in the United States

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

National trends in antiobesity medication use.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Use and abuse of appetite-suppressant drugs in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

National trends in the use and costs of anti-obesity medications in England 1998-2005.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Sibutramine lost and found

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Weight management in obesity - past and present

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

The epidemiology of obesity: the size of the problem

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Adverse drug reaction reporting by patients in the Netherlands: three years of experience

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Patients as a direct source of information on adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Assessment of a new instrument for detecting preventable adverse drug reactions.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

The monitoring medicines project: a multinational pharmacovigilance and public health project

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

21 January 2018

Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comment on: "Adverse drug reaction reporting by patients: an overview of fifty countries"

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Direct reporting of side effects by the patient: favourable experience in the first year]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychotomimetic effects of anorectic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressants and adverse effects in young patients: uncovering the evidence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27478924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SSRI treatment for under-18s

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2016.135

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/IJO.2016.135

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27478924%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39538570&oldid=1462471959"